Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Luckily for you, we at StockStory have no conflicts of interest - our sole job is to help you find genuinely promising companies. That said, here is one stock where Wall Street’s excitement appears well-founded and two where its enthusiasm might be excessive.
Two Stocks to Sell:
Bark (BARK)
Consensus Price Target: $3 (146% implied return)
Making a name for itself with the BarkBox, Bark (NYSE:BARK) specializes in subscription-based, personalized pet products.
Why Are We Wary of BARK?
- Performance surrounding its orders has lagged its peers
- Historical operating losses point to an inefficient cost structure
- Low free cash flow margin of 1.3% for the last two years gives it little breathing room, constraining its ability to self-fund growth or return capital to shareholders
Bark’s stock price of $1.22 implies a valuation ratio of 94.3x forward P/E. To fully understand why you should be careful with BARK, check out our full research report (it’s free).
Integer Holdings (ITGR)
Consensus Price Target: $148.75 (25.7% implied return)
With its name reflecting the mathematical term for "whole" or "complete," Integer Holdings (NYSE:ITGR) is a medical device outsource manufacturer that produces components and systems for cardiac, vascular, neurological, and other medical applications.
Why Does ITGR Worry Us?
- Annual revenue growth of 6.5% over the last five years was below our standards for the healthcare sector
- Subscale operations are evident in its revenue base of $1.75 billion, meaning it has fewer distribution channels than its larger rivals
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 7.7 percentage points
Integer Holdings is trading at $118.31 per share, or 18.8x forward P/E. Read our free research report to see why you should think twice about including ITGR in your portfolio.
One Stock to Buy:
Graham Corporation (GHM)
Consensus Price Target: $52.67 (43.2% implied return)
Founded when its founder patented a unique design for a vacuum system used in the sugar refining process, Graham (NYSE:GHM) provides vacuum and heat transfer equipment for the energy, petrochemical, refining, and chemical sectors.
Why Should You Buy GHM?
- Market share has increased this cycle as its 17% annual revenue growth over the last five years was exceptional
- Earnings per share grew by 298% annually over the last two years, massively outpacing its peers
- Free cash flow margin expanded by 5.6 percentage points over the last five years, providing additional flexibility for investments and share buybacks/dividends
At $36.79 per share, Graham Corporation trades at 30.9x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.
Stocks We Like Even More
Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs.
While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 176% over the last five years.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today for free.